Empowering patients to be their own personal trainers to improve function and strength - Implementing NICE CG79
The programme demonstrates the implementation of NICE guideline CG79 for management of rheumatoid arthritis in adults. It specifically relates to the delivery of recommendations that patients should have access to specialist physiotherapy, with periodic review. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 20, 2017 Category: Consumer Health News Source Type: news

Biosimilars: Bringing Patients into the Conversation
There ’s no doubt that the cheaper cost of biosimilars versus their originator biologic, even though not as substantial as generics, make them very attractive to healthcare markets. But so far, biosimilar manufacturers have dedicated most of their efforts to convincing payers of thesecost benefits, seeing them as the primary gatekeeper of market access. However, by focusing just on payers, are they missing a trick? In the longer-term, manufacturers could benefit from educating and winning over a wider audience, and not justphysicians, but also patients.Cheaper prices should lead to greater access to biologic therapy,...
Source: EyeForPharma - January 20, 2017 Category: Pharmaceuticals Authors: Mariel Metcalfe Source Type: news

Rheumatoid Arthritis: 17 Warning Signs of Serious Complications
Title: Rheumatoid Arthritis: 17 Warning Signs of Serious ComplicationsCategory: Doctor's& Expert's views on SymptomsCreated: 7/7/2001 12:00:00 AMLast Editorial Review: 1/20/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 20, 2017 Category: Rheumatology Source Type: news

Rheumatoid Arthritis (RA): 17 Warning Signs of Serious Complications
Title: Rheumatoid Arthritis (RA): 17 Warning Signs of Serious ComplicationsCategory: Doctor's& Expert's views on SymptomsCreated: 7/7/2001 12:00:00 AMLast Editorial Review: 1/20/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 20, 2017 Category: Rheumatology Source Type: news

Living With Rheumatoid Arthritis
Title: Living With Rheumatoid ArthritisCategory: Doctor's& Expert's views on SymptomsCreated: 8/9/2006 12:00:00 AMLast Editorial Review: 1/20/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 20, 2017 Category: Rheumatology Source Type: news

MedImmune gets OK from China to pursue arthritis drug in joint venture deal
Gaithersburg-based MedImmune is expanding its footprint in China's drug market after receiving a permit to begin clinical trials there on a biologic therapy for rheumatoid arthritis. MedImmune, which is the R&D arm for London-based AstraZeneca (NYSE: AZN) drug giant AstraZeneca, produced the biologic in a joint venture with leading Chinese biologics manufacturer WuXi AppTech. This is the first collaboration of its kind between an multinational pharmaceutical corporation and a Chinese company, said… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 19, 2017 Category: American Health Authors: Tina Reed Source Type: news

Early Diagnosis of Rheumatoid Arthritis in Primary Care
Primary care physicians may contribute to improved outcomes by recognizing the signs and symptoms early on. Part 2 of a Special Report. (Source: ConsultantLive)
Source: ConsultantLive - January 17, 2017 Category: Internal Medicine Authors: Kevin D. Deane, MD, PhD Sarah Dill, MD Tags: Special Report Musculoskeletal Disorders Source Type: news

Rheumatoid Arthritis
(RA) (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 17, 2017 Category: Journals (General) Source Type: news

US FDA extends review period for Eli Lilly and Incyte ’s rheumatoid arthritis treatment
The US Food and Drug Administration (FDA) has extended the review period for the new drug application (NDA) for Eli Lilly and Incyte ’s investigational baricitinib used to treat patients suffering from moderate-to-severe rheumatoid arthritis (RA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - January 16, 2017 Category: Pharmaceuticals Source Type: news

U.S. FDA Extends Review Period For Baricitinib, An Investigational Rheumatoid Arthritis Treatment
INDIANAPOLIS, Jan. 13, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the new drug application (NDA)... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - January 13, 2017 Category: Drugs & Pharmacology Source Type: news

Rheumatoid Arthritis: Mortality Gap Narrows Rheumatoid Arthritis: Mortality Gap Narrows
Post-2000 treat-to-target regimens may underlie a drop in relative 5-year all-cause, cardiovascular, and cancer deaths among patients with early RA vs those in the general population.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 12, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Ultrasound Imaging of Joints in Rheumatoid Arthritis (RA)
Title: Ultrasound Imaging of Joints in Rheumatoid Arthritis (RA)Category: Doctor's& Expert's views on SymptomsCreated: 2/6/2001 12:00:00 AMLast Editorial Review: 1/11/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 11, 2017 Category: Rheumatology Source Type: news

Rheumatoid Arthritis in Primary Care
This Special Report details the expanding role PCPs can play in serving an increasingly underserved population. (Source: ConsultantLive)
Source: ConsultantLive - January 9, 2017 Category: Internal Medicine Authors: Kevin D. Deane, MD, PhD Sarah Dill, MD Tags: Special Report Musculoskeletal Disorders Source Type: news

Pfizer reports positive top-line data from REFLECTIONS B538-02 study of PF-06410293
Pfizer has reported positive top-line data from its REFLECTIONS B538-02 study of PF-06410293 compared with Humira to treat moderate-to-severe rheumatoid arthritis (RA). (Source: Drug Development Technology)
Source: Drug Development Technology - January 9, 2017 Category: Pharmaceuticals Source Type: news

How BPA Exposure Lowers Vitamin D Levels
What do breast cancer, ADHD, diabetes, male fertility and autism have in common? They're very different conditions, but they've all been linked to a toxic group of chemicals called phthalates that we're all exposed to every day. Phthalates are in everything from food packaging to personal care products to dental fillings. In fact, they're so common in our environment that they're sometimes called "everywhere chemicals." And like so many of the toxins in our environment, phthalates throw your hormones out of whack. They cause estrogen levels to soar in both men and women. Chemicals like these a...
Source: Al Sears, MD Natural Remedies - January 6, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Health Nutrition Source Type: news

Identifying Subtypes of Rheumatoid Arthritis Identifying Subtypes of Rheumatoid Arthritis
From the ACR meeting in Washington, DC, Dr Laura Donlin discusses her research exploring how subtyping rheumatoid arthritis could lead to more personalized treatment.Medscape Rheumatology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - January 3, 2017 Category: Pathology Tags: Rheumatology Expert Interview Source Type: news

Why New Drug Approvals Are At A Six-Year Low In The U.S.
LONDON (Reuters) - Last year turned out to be a disappointing one for new drug approvals with the U.S. Food and Drug Administration clearing just 22 new medicines for sale, the lowest number since 2010 and sharply down on 2015’s tally of 45. Across the Atlantic, the European Medicines Agency recommended 81 new prescription products against a 2015 total of 93. Unlike the FDA, the EMA includes generic drugs in its list. The slowdown suggests the pharmaceuticals industry may be returning to more normal productivity levels after a spike in approvals in 2014 and 2015, when the haul of new drugs reaching the market hit a 1...
Source: Science - The Huffington Post - January 3, 2017 Category: Science Source Type: news

ICER issues draft report on rheumatoid arthritis treatments
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 31, 2016 Category: Drugs & Pharmacology Source Type: news

Coping with arthritis: What you do isn't associated with how much information you want
(Bentham Science Publishers) Arthritis patients were more likely to be high monitors (health detail oriented) than high blunters (health detail avoidant) in a study led by the University of North Carolina Eshelman School of Pharmacy. Study findings suggest that the attentional coping styles of patients with rheumatoid arthritis and osteoarthritis tend not to be associated with self-management behaviors such as how often patients have medication related discussions with their doctors and medication adherence. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 29, 2016 Category: Global & Universal Source Type: news

Carrie Fisher's Death Highlights The Reality Of Heart Disease In Women
Carrie Fisher died early Tuesday morning, four days after suffering a heart attack on a flight from London to Los Angeles. The actress and author, best known for her iconic role as Princess Leia in the “Star Wars” franchise, was 60 years old.  Experts say that Fisher’s death highlights an important reality about heart disease: It is the leading cause of death among men and women alike in the U.S. While heart disease encompasses many different conditions, a heart attack occurs when coronary arteries become blocked and oxygenated blood can’t reach the heart. About 735,000 Americans have hea...
Source: Science - The Huffington Post - December 28, 2016 Category: Science Source Type: news

Carrie Fisher's Death Highlights The Reality Of Heart Disease In Women
Carrie Fisher died early Tuesday morning, four days after suffering a heart attack on a flight from London to Los Angeles. The actress and author, best known for her iconic role as Princess Leia in the “Star Wars” franchise, was 60 years old.  Experts say that Fisher’s death highlights an important reality about heart disease: It is the leading cause of death among men and women alike in the U.S. While heart disease encompasses many different conditions, a heart attack occurs when coronary arteries become blocked and oxygenated blood can’t reach the heart. About 735,000 Americans have hea...
Source: Healthy Living - The Huffington Post - December 28, 2016 Category: Consumer Health News Source Type: news

Biomarkers Predict Rituximab Response in RA (CME/CE)
(MedPage Today) --'A further step towards the goal of personalized medicine'in rheumatoid arthritis (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - December 28, 2016 Category: Geriatrics Source Type: news

What is rheumatoid arthritis? Chronic condition is caused by your OWN immune system
RHEUMATOID arthritis is a long-term condition that causes pain, swelling and stiffness in the joints and mainly affects the hands feet and wrists. (Source: Daily Express - Health)
Source: Daily Express - Health - December 28, 2016 Category: Consumer Health News Source Type: news

Migraine drugs may repeat rheumatoid arthritis success
(Reuters) - Nearly two decades ago, several drugs to treat rheumatoid arthritis hit the shelves in rapid succession, opening up a huge market for the treatment of the autoimmune joint disorder. (Source: Reuters: Health)
Source: Reuters: Health - December 23, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Olumiant (baricitinib) Oral Treatment for Rheumatoid Arthritis
Information regarding Olumiant (baricitinib) for the treatment of adults with moderate to severe active rheumatoid arthritis (Source: Disabled World)
Source: Disabled World - December 22, 2016 Category: Disability Tags: Pharmaceutical - Drug Information Source Type: news

The Secret To Treating Autoimmune Disease May Lie In The Gut
An estimated 50 million Americans ― that’s 20 percent of the general population ― suffer from autoimmune diseases like lupus, multiple sclerosis or rheumatoid arthritis, and many experts say that number is rising at an alarming rate.  Autoimmunity occurs when the immune system begins attacking the body’s healthy tissue as if it were an outside invader, leading to chronic inflammation. We still don’t know much about what causes the immune system to go haywire, or how to effectively treat it. But new research suggests that the gut microbiome ― the community of trillions of “g...
Source: Science - The Huffington Post - December 21, 2016 Category: Science Source Type: news

The Secret To Treating Autoimmune Disease May Lie In The Gut
An estimated 50 million Americans ― that’s 20 percent of the general population ― suffer from autoimmune diseases like lupus, multiple sclerosis or rheumatoid arthritis, and many experts say that number is rising at an alarming rate.  Autoimmunity occurs when the immune system begins attacking the body’s healthy tissue as if it were an outside invader, leading to chronic inflammation. We still don’t know much about what causes the immune system to go haywire, or how to effectively treat it. But new research suggests that the gut microbiome ― the community of trillions of “g...
Source: Healthy Living - The Huffington Post - December 21, 2016 Category: Consumer Health News Source Type: news

CHMP Backs Baricitinib, Lifmior for Plaque Psoriasis and More CHMP Backs Baricitinib, Lifmior for Plaque Psoriasis and More
The EMA's CHMP recommended baricitinib for rheumatoid arthritis and Lifmior for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis, and plaque psoriasis.International Approvals (Source: Medscape Nurses Headlines)
Source: Medscape Nurses Headlines - December 19, 2016 Category: Nursing Tags: Rheumatology News Alert Source Type: news

Discovery's Edge: Linking gut bacteria to Rheumatoid Arthritis
The cause of rheumatoid arthritis, a systemic autoimmune disease, is unknown. But certain genes and environmental factors, such as smoking, are linked to the disease process. Now Mayo Clinic research suggests a new link: the composition of gut microbes. Veena Taneja, Ph.D., an immunologist at Mayo Clinic?s Center for Individualized Medicine, recently demonstrated a relationship [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 19, 2016 Category: Databases & Libraries Source Type: news

Gum disease bug linked to rheumatoid arthritis
Conclusions This research aimed to investigate a possible bacterial origin of rheumatoid arthritis and found one potential candidate – Aggregatibacter actinomycetemcomitans (Aα). It seems these bacteria could cause the high levels of citrullinated proteins which are known to trigger an immune reaction in people with rheumatoid arthritis. However, it's important to put these findings into the right context. Though antibodies against citrullinated proteins, anti-cyclic citrullinated peptide (anti-CCP), are one of the possible diagnostic findings in people with rheumatoid arthritis – not everyone w...
Source: NHS News Feed - December 19, 2016 Category: Consumer Health News Tags: Medical practice Source Type: news

CHMP Backs Baricitinib, Lifmior for Rheumatoid Arthritis CHMP Backs Baricitinib, Lifmior for Rheumatoid Arthritis
The EMA's CHMP recommended baricitinib for rheumatoid arthritis and Lifmior for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis, and plaque psoriasis.International Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 16, 2016 Category: Dermatology Tags: Rheumatology News Alert Source Type: news

Brushing your teeth could prevent arthritis, experts say
The discovery by researchers at Johns Hopkins University adds to evidence that rheumatoid arthritis is linked with dental health, a theory that has been suspected for a long time. (Source: the Mail online | Health)
Source: the Mail online | Health - December 16, 2016 Category: Consumer Health News Source Type: news

Brush teeth to beat Arthritis: Bugs that cause gum disease linked to rheumatoid arthritis
BRUSHING your teeth could help ward off the agony of rheumatoid arthritis, according to new research. (Source: Daily Express - Health)
Source: Daily Express - Health - December 16, 2016 Category: Consumer Health News Source Type: news

New partnership forms to accelerate arthritis therapy
A new partnership, named the M40 alliance, has been launched to accelerate the development of novel treatments for arthritis. The new venture is supported by a£7 million investment from the Kennedy Trust for Rheumatology Research.The M40 alliance will develop a network of consultants, nurses and clinical researchers in clinical units along the M40 corridor, based on a partnership between the Universities of Oxford and Birmingham, with other hubs in the area also involved. It will harness the existing research strengths of both universities in order to accelerate the development and testing of new therapies for patien...
Source: Arthritis Research UK - December 16, 2016 Category: Rheumatology Source Type: news

Germ may link gum disease and rheumatoid arthritis
Randy Dotinga, HealthDay News A specific germ may help explain the long-noticed connection between gum disease and rheumatoid arthritis, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 15, 2016 Category: Consumer Health News Source Type: news

Could a Germ Link Gum Disease, Rheumatoid Arthritis?
Study may offer new insight into the cause of the joint disorder Source: HealthDay Related MedlinePlus Pages: Bacterial Infections, Gum Disease, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 15, 2016 Category: Consumer Health News Source Type: news

Could a Germ Link Gum Disease, Rheumatoid Arthritis?
THURSDAY, Dec. 15, 2016 -- A specific germ may help explain the long-noticed connection between gum disease and rheumatoid arthritis, a new study suggests. The discovery might also point to the potential origins of the painful joint illness. " If... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 15, 2016 Category: Journals (General) Source Type: news

Could a Germ Link Gum Disease, Rheumatoid Arthritis?
Title: Could a Germ Link Gum Disease, Rheumatoid Arthritis?Category: Health NewsCreated: 12/15/2016 12:00:00 AMLast Editorial Review: 12/15/2016 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - December 15, 2016 Category: Rheumatology Source Type: news

Researchers add to evidence that common bacterial cause of gum disease may drive rheumatoid arthritis
New evidence suggests that a bacterium known to cause chronic inflammatory gum infections also triggers the inflammatory “autoimmune” response characteristic of chronic, joint-destroying rheumatoid arthritis (RA). The new findings have important implications for prevention and treatment of RA, say the researchers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 14, 2016 Category: Science Source Type: news

Invisible symptoms impact rheumatoid arthritis patients' lives, hinder diagnosis
(Health Union) Rheumatoid Arthritis In America 2016, a national survey by Health Union of more than 3,100 individuals with rheumatoid arthritis (RA), reveals that initial symptoms are often invisible to others, with respondents experiencing more than six on average. Among respondents, receiving a diagnosis often proved difficult with the average time between initial symptoms and diagnosis spanning four years. In addition, respondents feel stigmatized for often not looking sick and the unpredictable nature of the health condition. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 14, 2016 Category: Global & Universal Source Type: news

Workplace adjustments 'can help rheumatoid arthritis patients return to work'
Workplaces could be doing more to adjust their practices and provide greater flexibility in order to help rheumatoidarthritis patients return to work. This is according to a new study from Lancaster University and the Arthritis Research UK-MRC Centre for Musculoskeletal Health and Work, which aimed to offer a different viewpoint on sickness presenteeism, or the practice of continuing to work despite illness. A strong desire to work despite rheumatoid arthritis Generally speaking, sickness presenteeism is seen as having negative consequences for businesses and individuals alike, yet equally there is a perception that return...
Source: Arthritis Research UK - December 14, 2016 Category: Rheumatology Source Type: news

Toward New Treatment Targets in Rheumatoid Arthritis Toward New Treatment Targets in Rheumatoid Arthritis
From the ACR meeting in Washington, DC, Dr Lionel Ivashkiv discusses his research into promising new treatment approaches in inflammatory arthritis.Hospital for Special Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 13, 2016 Category: Consumer Health News Tags: Rheumatology Expert Interview Source Type: news

One in five worried about being fit enough to work next year
Results of a new survey released today have revealed that Great Britain is a nation of 'put up and shut up' when it comes to workplace health.Over 2,000 people were questioned about their attitudes and experience regarding health and the workplace. Results showed that:1 in 5 (20%) of people are worried they won't be fit enough to continue working in the next year.39% don't feel confident discussing their workplace health with their employer.A third of people (33%) with a long-term condition felt their colleagues don't understand the impact of their condition.Over 1 in 7 (15%) wouldn't disclose a long-term health ...
Source: Arthritis Research UK - December 8, 2016 Category: Rheumatology Source Type: news

Tocilizumab in RA With Inadequate Response to Methotrexate Tocilizumab in RA With Inadequate Response to Methotrexate
Does the addition of or switch to tocilizumab provide any additional benefits for rheumatoid arthritis patients who do not sufficiently respond to methotrexate alone?Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 7, 2016 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Adverse Events of Glucocorticoids During Treatment of RA Adverse Events of Glucocorticoids During Treatment of RA
What do we know about the adverse effects of glucocorticoids in rheumatoid arthritis -- and how are they best managed?Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 7, 2016 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Updating Systematic Reviews: A PCORI Virtual Multi-Stakeholder Workshop on Drug Therapy for Rheumatoid Arthritis in Adults
Monday, December 12, 2016 - 10:00 am to 12:00 pm EST (Source: HSR Information Central)
Source: HSR Information Central - December 6, 2016 Category: Global & Universal Source Type: news

Novimmune and Genentech enter exclusive licence agreement for rheumatoid arthritis drug
Swiss Biotech firm Novimmune has entered into an option and licence agreement with Roche company Genentech to develop and commercialise its anti-toll-like receptor 4 (TLR4) monoclonal antibody, NI-0101, to treat rheumatoid arthritis and other auto-im … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - December 6, 2016 Category: Pharmaceuticals Source Type: news

Nerve Treatment When Drugs Fail
To help migraines, rheumatoid arthritis and other conditions, scientists try stimulating the vagus nerve, the same part of the nervous system activated by breathing exercise during meditation. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 5, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news

Methotrexate ‘ Dramatically ’ Underused for RA Methotrexate ‘ Dramatically ’ Underused for RA
Methotrexate, the"anchor" drug for rheumatoid arthritis (RA), is"dramatically underutilized in clinical practice," researchers report.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - December 1, 2016 Category: Orthopaedics Tags: Rheumatology News Source Type: news